D100G (p.Asp100Gly) variant of ATRX (Chromatin remodeler ATRX)

D100G (p.Asp100Gly) in ATRX (Chromatin remodeler ATRX) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.

D100G (p.Asp100Gly) variant details